Additionally, the circulating omentin-1 concentrations positively correlated with obesity-related markers, such as body mass index (BMI) and waist–hip ratio (WHR), as well as prostate-specific antigen (PSA)—one of the basic markers determined in prostate cancer screening. Here, KLK3 is linked to obesity disorder.